AIB_016_Armon_Sharei_Web_03.jpg

SQZ Biotech's innovative approach to cell transformation is being validated by a $500 MM collaboration with Roche, the biggest maker of cancer drugs, as well as by $24 million in VC money. 

Sal Daher, CFA is an investor in SQZ Biotech. I you'd like to consider investing alongside Sal in this type of company, please enter you e-mail address here: